ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
Teddyward
|
60 |
13K |
1 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
13K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
Teddyward
|
60 |
13K |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
13K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
Teddyward
|
60 |
13K |
1 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
13K
|
1
|
|
ASX - By Stock
|
NUH |
Re:
Review tally
|
|
Teddyward
|
1.2K |
254K |
5 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
1.2K
|
254K
|
5
|
|
ASX - By Stock
|
STO |
Re:
ACCR files against STO Chair Keith Spence
|
|
Teddyward
|
12 |
4.7K |
2 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
12
|
4.7K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Does UK NHS Viraleze study outperform Paxlovid
|
|
Teddyward
|
1 |
485 |
0 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
1
|
485
|
0
|
|
ASX - By Stock
|
STO |
Re:
ACCR files against STO Chair Keith Spence
|
|
Teddyward
|
12 |
4.7K |
5 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
12
|
4.7K
|
5
|
|
ASX - By Stock
|
EVN |
Re:
Ann: FY24 Half Year Financial Results and 2023 MROR Presentation
|
|
Teddyward
|
41 |
19K |
8 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
41
|
19K
|
8
|
|
ASX - By Stock
|
IAG |
Re:
Recent Share Price Weakness
|
|
Teddyward
|
12 |
4.4K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
12
|
4.4K
|
1
|
|
ASX - By Stock
|
STO |
Re:
ACCR files against STO Chair Keith Spence
|
|
Teddyward
|
12 |
4.7K |
5 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
12
|
4.7K
|
5
|
|
ASX - By Stock
|
ECL |
Re:
Ann: ECL completes sale of CMI Operations Pty Ltd to IPD Group
|
|
Teddyward
|
9 |
3.1K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
9
|
3.1K
|
1
|
|
ASX - By Stock
|
IAG |
Re:
Recent Share Price Weakness
|
|
Teddyward
|
12 |
4.4K |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
12
|
4.4K
|
1
|
|
ASX - By Stock
|
RFX |
Re:
Ann: Notice to proceed for 15 MWh microgrid project in US
|
|
Teddyward
|
42 |
11K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
42
|
11K
|
0
|
|
ASX - By Stock
|
CCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Teddyward
|
9 |
2.8K |
1 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9
|
2.8K
|
1
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Change in substantial holding
|
|
Teddyward
|
11 |
5.5K |
2 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
11
|
5.5K
|
2
|
|
ASX - By Stock
|
STO |
Re:
Ann: 2023 Annual reserves and resources statement
|
|
Teddyward
|
6 |
2.8K |
8 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
6
|
2.8K
|
8
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Change in substantial holding
|
|
Teddyward
|
11 |
5.5K |
0 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
11
|
5.5K
|
0
|
|
ASX - By Stock
|
STO |
Re:
Ann: 2023 Annual reserves and resources statement
|
|
Teddyward
|
6 |
2.8K |
5 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
6
|
2.8K
|
5
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Drilling Update for Giant Welchau Gas Prospect
|
|
Teddyward
|
27 |
12K |
8 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
27
|
12K
|
8
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Drilling Update for Giant Welchau Gas Prospect
|
|
Teddyward
|
27 |
12K |
4 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
27
|
12K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
VivaGel trial results, failure history and FDA appeal
|
|
Teddyward
|
2 |
838 |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
2
|
838
|
2
|
|
ASX - By Stock
|
YOW |
Re:
Ann: KBC: Bidder's Statement
|
|
Teddyward
|
1 |
796 |
0 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
1
|
796
|
0
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
Teddyward
|
91 |
31K |
2 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
91
|
31K
|
2
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Woodside concludes discussions with Santos
|
|
Teddyward
|
29 |
14K |
8 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
29
|
14K
|
8
|
|
ASX - By Stock
|
WDS |
Re:
Ann: Woodside concludes discussions with Santos
|
|
Teddyward
|
29 |
14K |
5 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
29
|
14K
|
5
|
|
ASX - By Stock
|
STO |
Re:
Ann: WDS: Woodside concludes discussions with Santos
|
|
Teddyward
|
28 |
15K |
3 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
28
|
15K
|
3
|
|
ASX - By Stock
|
STO |
Re:
Ann: WDS: Woodside concludes discussions with Santos
|
|
Teddyward
|
28 |
15K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
28
|
15K
|
2
|
|
ASX - By Stock
|
WDS Oil & Gas |
Re:
WDS/STO merger may be close to finalising...; Short/Mid term Share Price impact any?
|
|
Teddyward
|
19 |
10K |
5 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
19
|
10K
|
5
|
|
ASX - By Stock
|
WDS Oil & Gas |
Re:
WDS/STO merger may be close to finalising...; Short/Mid term Share Price impact any?
|
|
Teddyward
|
19 |
10K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
19
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
REBIRTH OR REINVENTION OF STARPHARMA
|
|
Teddyward
|
38 |
9.5K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
38
|
9.5K
|
1
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Nuheara Q2 FY24 Business Update
|
|
Teddyward
|
234 |
45K |
0 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
234
|
45K
|
0
|
|
ASX - By Stock
|
NUH |
Re:
Ann: Nuheara Q2 FY24 Business Update
|
|
Teddyward
|
234 |
45K |
8 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
234
|
45K
|
8
|
|
ASX - By Stock
|
SUN |
Re:
Is your insurance cost going through the roof?
|
|
Teddyward
|
1 |
576 |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
1
|
576
|
0
|
|
ASX - By Stock
|
IAG |
Re:
Recent Share Price Weakness
|
|
Teddyward
|
12 |
4.4K |
2 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
12
|
4.4K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Trial Centre Monepantel Pharmaust
|
|
Teddyward
|
8 |
1.9K |
8 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
8
|
1.9K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Trial Centre Monepantel Pharmaust
|
|
Teddyward
|
8 |
1.9K |
7 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
8
|
1.9K
|
7
|
|
ASX - By Stock
|
STO |
Re:
News: STO Kumul Petroleum Updates On Amendments To Existing Finance Arrangements With Santos
|
|
Teddyward
|
1 |
537 |
4 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
1
|
537
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
Teddyward
|
239 |
129K |
13 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
239
|
129K
|
13
|
|
ASX - By Stock
|
WDS |
Re:
News: WDS Woodside should walk away from Santos deal, large shareholder says
|
|
Teddyward
|
2 |
1.3K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
2
|
1.3K
|
1
|
|
ASX - By Stock
|
NUH |
Re:
Expected Revenue
|
|
Teddyward
|
317 |
55K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
317
|
55K
|
4
|
|
ASX - By Stock
|
STO |
Re:
News: STO Woodside CEO says precedent for M&A in oil and gas sector is for low to no premium
|
|
Teddyward
|
39 |
17K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
17K
|
4
|
|
ASX - By Stock
|
STO |
Re:
News: STO Woodside CEO says precedent for M&A in oil and gas sector is for low to no premium
|
|
Teddyward
|
39 |
17K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
17K
|
4
|
|
ASX - By Stock
|
STO |
Re:
News: STO Woodside CEO says precedent for M&A in oil and gas sector is for low to no premium
|
|
Teddyward
|
39 |
17K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
39
|
17K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
VIRALEZE™ nasal spray a blow for covid
|
|
Teddyward
|
37 |
6.3K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
37
|
6.3K
|
1
|
|
ASX - By Stock
|
YOW |
Re:
Ann: Keybridge Capital Ltd Takeover Offer
|
|
Teddyward
|
2 |
1.1K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
YOW |
Re:
Ann: Keybridge Capital Ltd Takeover Offer
|
|
Teddyward
|
2 |
1.1K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
NUH |
Re:
Expected Revenue
|
|
Teddyward
|
317 |
55K |
4 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
317
|
55K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Teddyward
|
23 |
5.0K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
23
|
5.0K
|
1
|
|
ASX - By Stock
|
YOW |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Teddyward
|
1 |
557 |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
1
|
557
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
Teddyward
|
40 |
7.8K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
40
|
7.8K
|
1
|
|